Hosted on MSN1mon
Dr Reddy's in pact with Shanghai Henlius Biotech for exclusive US, Europe rights for daratumumab biosimilarHYDERABAD: Dr Reddy’s Laboratories SA, the wholly-owned Swiss subsidiary of Hyderabad-based pharma biggie Dr Reddy’s Laboratories Ltd, has entered into a licence agreement with Shanghai ...
In a significant move to reduce the financial burden on patients battling life-threatening diseases, Finance Minister Nirmala Sitharaman announced a full exemption from basic customs duty on ...
Erez Israeli, Chief Executive Officer of Dr. Reddy's, said: "We are pleased to collaborate with Henlius to make this daratumumab biosimilar available to patients in the U.S., and Europe.
To Pay Chinese player up to $131.6 million for subcutaneous & intravenous formulations of HLX15 “The agreement combines Dr Reddy’s global commercial presence with Henlius’ proven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results